Bharat Biotech Intranasal Vaccine (E)

Bharat Biotech may soon succeed in developing another vaccine against COVID- 19. Recently, an expert panel of Central Drug Standards Control Organization gave green signal to Bharat Biotech to conduct Phase one clinical trial of its intranasal vaccine. Phase one trials of the intranasal vaccine may begin as soon as February or March.

Related Videos